Target intelligence / Profile preview

Gentamicin

Molecular classification
Other (antibiotic, aminoglycoside family)
01

Overview

Gentamicin is an aminoglycoside antibiotic naturally produced by Micromonospora species and is used to treat invasive infections caused by aerobic Gram-negative and some Gram-positive bacteria, including Pseudomonas, Escherichia coli, and Staphylococcus species. It is not a receptor, enzyme, transporter, or other typical therapeutic target but is the active drug substance itself. Gentamicin acts by binding irreversibly to the bacterial 30S ribosomal subunit, blocking protein synthesis and causing cell death. It is effective for bloodstream infections, pneumonia, urinary tract infections, meningitis, bone and soft tissue infections, among others. Use is limited by possible toxicity to the kidneys and inner ear, with permanent damage possible. Combination with other antibiotics, such as beta-lactam drugs, can result in a synergistic effect. Due to its toxicity profile and specific indication spectrum, use is often reserved for serious infections with susceptibility confirmed by culture and sensitivity testing.

Other names
Garamycin
02

Mechanism of action

Inhibits bacterial protein synthesis by binding irreversibly to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting translocation

03

Biological functions

Other (antibacterial activity)
04

Disease associations

Infection
05

Safety considerations

Nephrotoxicity (kidney damage)Ototoxicity (hearing and balance problems, which may be permanent)Risk of fetal harm in pregnancyRequires therapeutic drug monitoring
06

Interacting drugs

Carbenicillin

2 more in the full profile.

Beyond the preview

Go deeper on Gentamicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gentamicin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call